Merger creates company with combined revenues of more than EUR 1.7bn
合并后,新公司年收入将超过17亿欧元
Transaction expected to close in early March 2019
合并预计将于2019年3月初完成
Truly global footprint through comprehensive sales and distribution platform
真正实现销售和分销的全球化
Singapore and Lynge, Denmark – February 14, 2019: The European Commission has approved, under the EU Merger Regulation, the merger between Sivantos Pte. Ltd. (“Sivantos”), owned by EQT funds, and Widex A/S (“Widex”), owned by T&W Medical A/S.
新加坡和丹麦Lynge – 2019年2月14日:欧洲联盟委员会批准了西万拓Sivantos(由EQT基金拥有)和唯听Widex A/S(由T&W医疗A/S公司拥有)两家公司的合并提案。
Sivantos offers a diverse portfolio of technologically advanced hearing aid products across brands like Signia, Audio Service, Rexton and others. Widex’ portfolio of products includes a range of sophisticated hearing aid technology with a focus on the high-end segment.
西万拓Sivantos旗下拥有源自西门子听力的西嘉Signia、奥德声Audio Service、力斯顿Rexton等品牌,提供先进的助听器产品组合,唯听Widex产品组合包括一系列尖端助听器技术,并主打高端助听器产品。
The Commission concluded the merger would raise no competition concerns. The merger has already been approved in all other relevant jurisdictions.
欧盟委员认为,两家公司的合并不会导致同业竞争。合并已获得两公司所在司法管辖区的批准。
“Our goal at Widex has always been to develop the best possible hearing aids to improve the life of those with hearing needs. The merger with Sivantos brings us one step closer to that goal by building a company with one of the strongest research and development resources in the business and the sales channels to ensure our innovative products reach as many people as possible,” said Jan Tøpholm, Chairman of Widex A/S.
唯听Widex A/S公司董事长Jan Tøpholm表示:“唯听Widex一直以科技研发为己任,并致力于改善听障人士的生活质量。”,“与西万拓集团的合并极大地扩展了双方的业务资源和销售渠道,让我们离目标又进了一步,从而让我们的创新产品可以够帮助更多的听障人士。”
“The merger between Widex and Sivantos is a transformative combination and unique opportunity to drive innovation through one of the most dynamic R&D teams in the industry to benefit the more than 700 million people with hearing needs,” said Marcus Brennecke, Global Co-Head of EQT Private Eq
上一条:全力支持中国市场,实现共赢发展
下一条:没有了